Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA(IMP) 32611 |
|---|---|
| 2: Name of authorisation holder | IMPERIAL COLLEGE HEALTHCARE NHS TRUST |
| 3: Address(es) of manufacturing site(s) |
JOHN GOLDMAN CENTRE FOR CELLULAR THERAPY, HAMMERSMITH HOSPITAL, DU CANE ROAD, LONDON, W12 0HS, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | IMPERIAL COLLEGE HEALTHCARE NHS TRUST, HAMMERSMITH HOSPITAL, DU CANE ROAD, LONDON, W12 0HS, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 17/12/2020 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:
JOHN GOLDMAN CENTRE FOR CELLULAR THERAPY, HAMMERSMITH HOSPITAL, DU CANE ROAD, LONDON, W12 0HS, UNITED KINGDOM
Human Investigational Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.1 ] Sterile Investigational Medicinal Products |
| [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) |
| [ 1.1.1.4 ] Small volume liquids |
| [ 1.3 ] Biological investigational medicinal products |
| [ 1.3.1 ] Biological medicinal products |
| [ 1.3.1.1 ] Blood products |
| [ 1.3.1.2 ] Immunological products |
| [ 1.3.1.3 ] Cell therapy products |
| [ 1.5 ] Packaging |
| [ 1.5.2 ] Secondary packaging |
| [ 1.6 ] Quality control testing |
| [ 1.6.4 ] Biological |